JOANNE RICHARDS to Mutation
This is a "connection" page, showing publications JOANNE RICHARDS has written about Mutation.
Connection Strength
0.559
-
Specific TP53 Mutants Overrepresented in Ovarian Cancer Impact CNV, TP53 Activity, Responses to Nutlin-3a, and Cell Survival. Neoplasia. 2015 Oct; 17(10):789-803.
Score: 0.181
-
Constitutively active FOXO1a and a DNA-binding domain mutant exhibit distinct co-regulatory functions to enhance progesterone receptor A activity. J Mol Endocrinol. 2007 Jun; 38(6):673-90.
Score: 0.102
-
Differences in gynecologic tumor development in Amhr2-Cre mice with KRASG12D or KRASG12V mutations. Sci Rep. 2020 11 26; 10(1):20678.
Score: 0.065
-
USP15-dependent lysosomal pathway controls p53-R175H turnover in ovarian cancer cells. Nat Commun. 2018 03 28; 9(1):1270.
Score: 0.054
-
From Follicular Development and Ovulation to Ovarian Cancers: An Unexpected Journey. Vitam Horm. 2018; 107:453-472.
Score: 0.053
-
Either Kras activation or Pten loss similarly enhance the dominant-stable CTNNB1-induced genetic program to promote granulosa cell tumor development in the ovary and testis. Oncogene. 2012 Mar 22; 31(12):1504-20.
Score: 0.034
-
Progesterone receptor-induced gene expression in primary mouse granulosa cell cultures. Biol Reprod. 2010 Feb; 82(2):402-12.
Score: 0.030
-
Cell type-specific targeted mutations of Kras and Pten document proliferation arrest in granulosa cells versus oncogenic insult to ovarian surface epithelial cells. Cancer Res. 2009 Aug 15; 69(16):6463-72.
Score: 0.030
-
Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas. PLoS One. 2015; 10(8):e0135101.
Score: 0.011